Bridget Mulvenna

Bridget Mulvenna

Director, Pharmacy Programs
Erickson Senior Living

Bridget Mulvenna is a Pharmacy Business Development professional with over 30 years of knowledge and experience in all pharmacy settings. Bridget has been employed by Erickson Senior Living since May 2014 as Director of Clinical Procurement and in February 2020, was promoted to Director of Pharmacy Programs. She is the Chairperson of the Pharmacy and Therapeutics Committee, manages the pharmacy component of the Erickson employee health plan, is actively developing an on-campus retail pharmacy model to benefit seniors and is a sought-after leader, public speaker and mentor. Prior to working for Erickson, Bridget was employed by Omnicare for over 8 years, where she held multiple roles in operations, sales, retention and project management. She is a voracious reader and loves yoga, Pilates and meditation. She has three adult sons (Jack (28), Bryce (24) and Trey (22)) and lives in New Market, MD with her husband, Bryan.

All Sessions by Bridget Mulvenna

Thinc Main Agenda Monday AM May 23, 2022
10:35 am - 11:20 am

Market Insight: PBM 2.0: Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology

The status quo PBM financial model and legacy technology platforms are failing the healthcare system and are in direct conflict with future state Value-Based Contracting models. New technology has entered the PBM ecosystem changing how members are serviced, drugs are priced and taming the runaway train of prescription drug costs.

Ecosystem stakeholders detail their experience with this next-generation PBM platform and financial framework that has created unprecedented alignment, value, and member experience while also providing prescription drug predictability and pricing equity.

Learn how new technology connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement and increasing efficiency to achieve the highest standards of clinical care. This panel will bring together healthcare stakeholders to provide the employer, payer, and provider perspectives on:

  • The impetus for building the only commercially available single ledger NADAC based PBM model and discussing the importance of alignment in drug pricing for patients, payers, and providers
  • How the newest PBM platform produces administrative efficiency while optimizing cost, member experience, and equity
  • How this next-generation PBM model provides employers what they really want around predictability in prescription drug spend and it is critical to future value-based contracts as our healthcare system evolves into outcomes-based contracting